These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34048484)

  • 1. Community led testing among people who inject drugs: A community centered model to find new cases of HIV and Hepatitis C in Nepal.
    Didiya R; Gyenwali D; Pokhrel TN; Devkota S; Rai AB; Shedain PR; Sharma M; Shrestha MK; Imran M; Kadirov Z; Dahal BP; K C P; Ojha S; Pokhrel KN
    PLoS One; 2021; 16(5):e0252490. PubMed ID: 34048484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.
    Karimi SE; Bayani A; Higgs P; Bayat AH; Hemmat M; Ahounbar E; Armoon B; Fakhri Y
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):64. PubMed ID: 32831107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
    Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
    Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
    Aitken CK; Agius PA; Higgs PG; Stoové MA; Bowden DS; Dietze PM
    Epidemiol Infect; 2017 Mar; 145(4):796-801. PubMed ID: 27927256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.
    Calin R; Massari V; Pialoux G; Reydellet N; Plenel E; Chauvin C; Jauffret-Roustide M; Day N; Kreplak G; Maresca AF; Derche N; Louis S; Pol S; Doré V; Rouzioux C; Chauvin P
    BMC Infect Dis; 2020 Nov; 20(1):851. PubMed ID: 33198672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study.
    Kumar A; Mahajan H; Chaturvedi S; Kumar A; Kumar S; Sahoo GC; Das VNR; Pandey K
    PLoS One; 2023; 18(6):e0287333. PubMed ID: 37319276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernández D
    Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia.
    Sopheab H; Chhea C; Tuot S; Muir JA
    BMC Infect Dis; 2018 Nov; 18(1):562. PubMed ID: 30424727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs.
    Trayner KMA; McAuley A; Palmateer NE; Goldberg DJ; Shepherd SJ; Gunson RN; Tweed EJ; Priyadarshi S; Milosevic C; Hutchinson SJ
    Int J Drug Policy; 2020 Mar; 77():102663. PubMed ID: 31981949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017.
    Bull-Otterson L; Huang YA; Zhu W; King H; Edlin BR; Hoover KW
    J Infect Dis; 2020 Aug; 222(6):940-947. PubMed ID: 32002537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal.
    Zaccheo SK; Marrone G; Pandey LR; Deuba K
    Int J Drug Policy; 2023 Sep; 119():104145. PubMed ID: 37549595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.